The company will instead produce authorized generic versions of the ... may include ArmonAir Digihaler and Arnuity Ellipta.

Now, it has decided to publish a special report on two of GSK's COPD therapies – Breo Ellipta (fluticasone ... to their respective fixed-dose generic alternatives or open generic combinations ...

Developed with US respiratory specialist firm Innoviva, the drug (known as Breo Ellipta in the US) is GSK’s follow up to its respiratory blockbuster Advair/Seretide, but won’t come close to ...

Discontinue and treat if paradoxical bronchospasm occurs; use alternative therapy. Cardiovascular disease (esp. coronary insufficiency, arrhythmias, hypertension). Convulsive disorders.